aiqbench analysis

The article focuses on applying AI techniques to optimize the traditionally inefficient process of pharmaceutical development, specifically addressing cost reduction and speed in target identification. By leveraging machine learning models, companies aim to break Eroom's Law through a closed-loop data system that accelerates clinical trial success rates. This represents a significant shift from traditional methods toward algorithmic efficiency in high-stakes biological research.